Description
Optimised Hyaluronic Acid Triple Action Matrix
The specific and optimised range of molecular weight of HA within Monovisc creates a matrix that supports joint cushioning, lubrication and endogenous stimulation.
With over 3 million injections worldwide since 2008, Monovisc is the world’s most trusted HA injection therapy for OA across multiple joints. No other HA single injection has been proven to outperform Monovisc.
- 57% improvement in WOMAC pain from baseline at 3 weeks
- 65% improvement in WOMAC pain at Week 26
- 85% responder rate through 26 Weeks
Joint preservation, joint longevity, joint motion – Pain-free.
- High concentration – 88mg per injection
- An optimised range of molecular weights, which allows for a longer therapeutic effect
- Lightly cross-linked, which leads to optimised joint residence time
Ultra pure, non-avian derived. Trusted fermentation technique with only 2% rate of mild injection reaction reported
